Time From Approval to Reimbursement of New Drugs: A Comparative Analysis Between the United States, England, Germany, France, and Switzerland (2011-2022).

Camille E G Glaus Miquel Serra-Burriel Stacie B Dusetzina Kerstin N Vokinger

Ann Intern Med

Professor of Law and Medicine, Academic Chair for Regulation in Law, Medicine, and Technology, Faculty of Law and Faculty of Medicine, University of Zurich, Zurich, Switzerland.

Published: October 2024

Download full-text PDF	Source
http://dx.doi.org/10.7326/ANNALS-24-00614	DOI Listing

Publication Analysis

Top Keywords

time approval

approval reimbursement

reimbursement drugs

drugs comparative

comparative analysis

analysis united

united states

states england

england germany

germany france

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!

Time From Approval to Reimbursement of New Drugs: A Comparative Analysis Between the United States, England, Germany, France, and Switzerland (2011-2022).

Download full-text PDF

Publication Analysis

Top Keywords

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?